Protein Biomarkers and Risk of Atrial Fibrillation

Laila Stærk; Sarah R. Preis; Honghuang Lin; Steven A. Lubitz; Patrick T. Ellinor; Daniel Levy; Emelia Benjamin; Ludovic Trinquart

doi:10.1161/circep.119.007607

Article2023

Abstract 18200: Prognostic Importance of Serial NT-proBNP Measurements Following High-Risk Mi: The PARADISE-MI Trial

Karola Jering, Brian Claggett, Marc A. Pfeffer, Christopher B. Granger, Lars Køber, Eldrin F. Lewis, Aldo Maggioni, Douglas L. Mann, John J.V. McMurray, Margaret F. Prescott, Jean L. Rouleau, Scott D. Solomon, Philippe Gabríel Steg, Dirk von Lewinski, Eugene Braunwald

Preprint2020

Total NT-proBNP, a novel biomarker in atrial fibrillation. A mechanistic analysis of the GISSI-AF trial

Lidia Staszewsky, Jennifer Meessen, Deborah Novelli, Ulla Wienhues-Thelen, M Disertori, Aldo Maggioni, Serge Masson, Gianni Tognoni, Maria Grazia Franzosi, Donata Lucci, Roberto Latini

Article2023

ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry

Yufeng Wang, Chao Jiang, Liu He, Xin Du, Xueyuan Guo, Ribo Tang, Caihua Sang, Deyong Long, Jianzeng Dong, Ziad Hijazi, Professor Gregory Lip, Changsheng Ma

Article2021

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation

Lidia Staszewsky, Jennifer Meessen, Deborah Novelli, Ursula‐Henrike Wienhues‐Thelen, M Disertori, Aldo Maggioni, Serge Masson, Gianni Tognoni, Maria Grazia Franzosi, Donata Lucci, Roberto Latini

Article2008

Abstract 2120: Circulating Markers of Myocyte Injury Predict First Recurrence of Atrial Fibrillation. Data from the GISSI-Atrial Fibrillation Trial

Serge Masson, Salvatore Pirelli, G. Pulitanò, Emanuele Carbonieri, Michele Massimo Gulizia, Tarcisio Vago, Simona Barlera, Aldo Maggioni, Maria Grazia Franzosi, M Disertori, Roberto Latini

Protein Biomarkers and Risk of Atrial Fibrillation

Abstract

Discussion(0)

Related publications

Abstract 18200: Prognostic Importance of Serial NT-proBNP Measurements Following High-Risk Mi: The PARADISE-MI Trial

Total NT-proBNP, a novel biomarker in atrial fibrillation. A mechanistic analysis of the GISSI-AF trial

ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation

Abstract 2120: Circulating Markers of Myocyte Injury Predict First Recurrence of Atrial Fibrillation. Data from the GISSI-Atrial Fibrillation Trial